ChemoMetec A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEMM.CO research report →
About the company
Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment.
- CEO
- Martin Helbo Behrens
- IPO
- 2006
- Employees
- 184
- HQ
- Allerød, DK
Price Chart
- Market Cap
- $6.38B
- P/E
- 36.03
- P/S
- 12.93
- P/B
- 9.77
- EV/EBITDA
- 24.81
- Div Yield
- 1.91%
- Gross Margin
- 80.29%
- Op Margin
- 47.26%
- Net Margin
- 35.90%
- ROE
- 26.70%
- ROIC
- 27.24%
- Revenue
- $495.57M · 21.50%
- Net Income
- $186.41M · 36.78%
- EPS
- $10.71 · 36.78%
- Op Income
- $247.68M
- FCF YoY
- 107.77%
- 52W High
- $804.00
- 52W Low
- $235.20
- 50D MA
- $343.54
- 200D MA
- $533.36
- Beta
- 1.34
- Avg Volume
- 90.17K
Get TickerSpark's AI analysis on CHEMM.CO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CHEMM.CO coverage
Recent articles, reports, and earnings notes.
No research on CHEMM.CO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHEMM.CO report →Similar companies
Peers in the same neighborhood.